Phibro Animal Health Corporation (NASDAQ:PAHC) COO Larry Lee Miller sold 15,891 shares of the stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $36.46, for a total transaction of $579,385.86. Following the completion of the transaction, the chief operating officer now directly owns 15,891 shares in the company, valued at $579,385.86. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Larry Lee Miller also recently made the following trade(s):

  • On Thursday, September 14th, Larry Lee Miller sold 21,439 shares of Phibro Animal Health Corporation stock. The shares were sold at an average price of $36.43, for a total transaction of $781,022.77.
  • On Tuesday, September 12th, Larry Lee Miller sold 46,102 shares of Phibro Animal Health Corporation stock. The shares were sold at an average price of $36.33, for a total transaction of $1,674,885.66.
  • On Thursday, September 7th, Larry Lee Miller sold 32,459 shares of Phibro Animal Health Corporation stock. The shares were sold at an average price of $35.59, for a total transaction of $1,155,215.81.

Shares of Phibro Animal Health Corporation (NASDAQ PAHC) traded down 0.97% on Friday, reaching $35.75. 267,714 shares of the company’s stock traded hands. The stock has a market capitalization of $1.43 billion, a PE ratio of 22.20 and a beta of 1.36. The company has a 50 day moving average of $37.99 and a 200-day moving average of $33.77. Phibro Animal Health Corporation has a 52 week low of $24.83 and a 52 week high of $40.25.

Phibro Animal Health Corporation (NASDAQ:PAHC) last issued its earnings results on Wednesday, August 30th. The company reported $0.39 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.35 by $0.04. The company had revenue of $194.84 million for the quarter, compared to analysts’ expectations of $192.47 million. Phibro Animal Health Corporation had a net margin of 8.45% and a return on equity of 47.88%. The firm’s revenue was up 3.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.32 earnings per share. Equities research analysts forecast that Phibro Animal Health Corporation will post $1.57 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Shareholders of record on Wednesday, September 6th will be issued a dividend of $0.10 per share. The ex-dividend date is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.12%. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is 24.69%.

TRADEMARK VIOLATION NOTICE: “Phibro Animal Health Corporation (PAHC) COO Larry Lee Miller Sells 15,891 Shares of Stock” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.thecerbatgem.com/2017/09/16/phibro-animal-health-corporation-pahc-coo-larry-lee-miller-sells-15891-shares-of-stock.html.

A number of research analysts recently commented on PAHC shares. Credit Suisse Group increased their target price on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the company an “outperform” rating in a research report on Thursday, August 31st. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $41.00 target price (down from $42.00) on shares of Phibro Animal Health Corporation in a research report on Thursday, August 31st. BidaskClub raised shares of Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 22nd. Finally, Bank of America Corporation reaffirmed an “underperform” rating and issued a $33.00 target price on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and five have given a buy rating to the stock. Phibro Animal Health Corporation presently has a consensus rating of “Hold” and a consensus price target of $34.00.

Several large investors have recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Phibro Animal Health Corporation by 3.0% during the second quarter. Vanguard Group Inc. now owns 1,780,880 shares of the company’s stock worth $65,982,000 after purchasing an additional 51,474 shares during the period. Wellington Management Group LLP raised its holdings in shares of Phibro Animal Health Corporation by 0.9% during the first quarter. Wellington Management Group LLP now owns 1,385,325 shares of the company’s stock worth $38,928,000 after purchasing an additional 11,950 shares during the period. FMR LLC raised its holdings in shares of Phibro Animal Health Corporation by 31.9% during the second quarter. FMR LLC now owns 584,463 shares of the company’s stock worth $21,654,000 after purchasing an additional 141,274 shares during the period. State Street Corp raised its holdings in shares of Phibro Animal Health Corporation by 6.1% during the first quarter. State Street Corp now owns 489,093 shares of the company’s stock worth $13,745,000 after purchasing an additional 28,273 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Phibro Animal Health Corporation by 5.0% during the second quarter. Dimensional Fund Advisors LP now owns 416,001 shares of the company’s stock worth $15,413,000 after purchasing an additional 19,994 shares during the period. 48.35% of the stock is currently owned by institutional investors.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Stock Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related stocks with our FREE daily email newsletter.